Prabal K. Chatterjee

Author

Also Known As

Kiyokazu Nakayama, P Chatterjee, P K Chatterjee, P.K. Chatterjee, PRABAL K. CHATTERJEE, Prabal Chatterjee, Prabal K Chatterjee, Prabal K. Chatterjee, Prabal Kumar Chatterjee

Publications

Citations

H-Index

Concepts

All Affiliations

William Harvey Research Institute University of Messina Queen Mary University of London University of Aberdeen University of Brighton

About

Prabal K. Chatterjee is an author at William Harvey Research Institute specializing in medicine, pharmacology, and oxidative stress.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	28	2.5K
2	Biochemistry	8	8	739
3	Cell Biology	4	4	130
4	Cellular Physiology	4	4	174
5	Natural Sciences	1	1	29

Prabal K. Chatterjee

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Ligands of the peroxisome proliferator‐activated receptors (PPAR‐γ and PPAR‐α) reduce myocardial infarct size Nicole S. Wayman, Yoshiyuki Hattori, Michelle C. McDonald, The FASEB Journal Heart FailureCardiovascular DiseaseBiochemistryAtherosclerosisDistinct Ligands	2002	359
Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat Prabal K. Chatterjee, Salvatore Cuzzocrea, Paul A. Brown, Kidney International OxysterolMedicineLipid PeroxidationPhysiologyToxicology	2000	351
Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury Prabal K. Chatterjee, Nimesh S. A. Patel, Espen Ø. Kvale, Kidney International InflammationReactive Nitrogen SpecieMedicineNitrosative StressEndothelial Dysfunction	2002	239
RETRACTED: Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation Salvatore Cuzzocrea, Maria Barbara Pisano, Laura Dugo, European Journal of Pharmacology InflammationAnti-inflammatoryMedicineImmunologyChronic Inflammation	2003	216
RETRACTED: Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation Salvatore Cuzzocrea, Prabal K. Chatterjee, Emanuela Mazzon, British Journal of Pharmacology	2002	210
Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo Nimesh S. A. Patel, Edward Sharples, Salvatore Cuzzocrea, Kidney International UrologyRenal FunctionReperfusion InjuryMedicinePhysiology	2004	207
Endogenous Interleukin-6 Enhances the Renal Injury, Dysfunction, and Inflammation Caused by Ischemia/Reperfusion Nimesh S. A. Patel, Prabal K. Chatterjee, Rosanna Di Paola, Journal of Pharmacology and Experimental Therapeutics	2005	174
Agonists of Peroxisome-Proliferator Activated Receptor-Gamma Reduce Renal Ischemia/Reperfusion Injury Ahila Sivarajah, Prabal K. Chatterjee, Nimesh S. A. Patel, American Journal of Nephrology	2003	149
GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury Prabal K. Chatterjee, Nimesh S. A. Patel, Ahila Sivarajah, Kidney International Ischemic SyndromeUrologyMedicineSelective InhibitorVascular Biology	2003	139
Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response After Postischemic Injury Salvatore Cuzzocrea, Prabal K. Chatterjee, Emanuela Mazzon, Shock	2002	127

Page 1